Susunod

Auto-play

Dr. Moskowitz on the ALCANZA Trial in CTCL

4 Mga view • 08/09/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Alison J. Moskowitz, MD, clinical director, Lymphoma Inpatient Unit, Memorial Sloan Kettering Cancer Center, discusses the data that led to the approval of brentuximab vedotin (Adcetris) in patients with cutaneous T-cell lymphoma (CTCL).

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play